SciForschen Online Publications

Publications

Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A, Matsuzaki J, Tsuji T, Groman A, Gnjatic S, Spagnoli G, Lele S, Odunsi K. Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer. PLoS One. 2014 Aug 7;9(8):e104099.
Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, Odunsi K. Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS One. 2014;9(1):e84941
Batt RE, Martin DC, Odunsi K. Endometriosis of the retrocervical septum is proposed to replace the anatomically incorrect term endometriosis of the rectovaginal septum. Hum Reprod. 2014 Oct 21. [Epub ahead of print]
Gil M, Komorowski MP, Seshadri M, Rokita H, McGray AJ, Opyrchal M, Odunsi KO, Kozbor D. CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells. J Immunol. 2014 Oct 15. [Epub ahead of print]
Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L; AOCS Study Group, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. Br J Cancer. 2014 Oct 30. [Epub ahead of print]
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka- Halasa J, Timorek A, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Narod SA, Risch HA, McLaughlin JR, Siddiqui N, Glasspool R, Paul J, Carty K, Gronwald J, Lubiński J, Jakubowska A, Cybulski C, Kiemeney LA, Massuger LF, van Altena AM, Aben KK, Olson SH, Orlow I, Cramer DW, Levine DA, Bisogna M, Giles GG, Southey MC, Bruinsma F, Kjaer SK, Høgdall E, Jensen A, Høgdall CK, Lundvall L, Engelholm SA, Heitz F, du Bois A, Harter P, Schwaab I, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Thompson PJ, Lurie G, Wilkens LR, Lambrechts D, Van Nieuwenhuysen E, Lambrechts S, Vergote I, Beesley J; AOCS Study Group/ACS Investigators, Fasching PA, Beckmann MW, Hein A, Ekici AB, Doherty JA, Wu AH, Pearce CL, Pike MC, Stram D, Chang-Claude J, Rudolph A, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Bogdanova N, Antonenkova N, Odunsi K, Edwards RP, Kelley JL, Modugno F, Ness RB, Karlan BY, Walsh C, Lester J, Orsulic S, Fridley BL, Vierkant RA, Cunningham JM, Wu X, Lu K, Liang D, Hildebrandt MA, Weber RP, Iversen ES, Tworoger SS, Poole EM, Salvesen HB, Krakstad C, Bjorge L, Tangen IL, Pejovic T, Bean Y, Kellar M, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Campbell IG, Eccles D, Whittemore AS, Sieh W, Rothstein JH, Anton-Culver H, Ziogas A, Phelan CM, Moysich KB, Goode EL, Schildkraut JM, Berchuck A, Pharoah PD, Sellers TA, Brooks-Wilson A, Cook LS, Le ND. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res. 2014 Jul 28. [Epub ahead of print]
Ma Y, Sun Z, de Matos R, Zhang J, Odunsi K, Lin B. Towards an animal model of ovarian cancer: Cataloging Chicken Blood Proteins Using Combinatorial Peptide Ligand Libraries Coupled with Shotgun Proteomics Analysis for Translational Research. OMICS: A Journal of Integrative Biology. 2014;18(5):280-97.
Odunsi K, Matsuzaki J, James SR, Mhawech-Fauceglia P, Tsuji T, Miller A, Zhang W, Akers S, Griffiths E, Miliotto A, Beck A, Batt CA, Ritter G, Lele S, Gnjatic S, Karpf AR . Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer. Cancer Immunol Res. 2014;2:37-49.
Matsuzaki J, Tsuji T, Luescher I, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Non- classical antigen processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4+ T cells. Cancer Immunol Res. 2014;2(4):341-50.
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, Wang C, Tyrer J, Song H, Defazio A, Johnatty SE, Doherty JA, Phelan CM, Sellers TA, Ramirez SM, Vitonis AF, Terry KL, Van Den Berg D, Pike MC, Wu AH, Berchuck A, Gentry-Maharaj A, Ramus SJ, Diergaarde B, Shen H, Jensen A, Menkiszak J, Cybulski C, Lubiłski J, Ziogas A, Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S, Despierre E, Garcia-Closas M, Yang H, Brinton LA, Spiewankiewicz B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A, Paddock LE, Orlow I, Lundvall L, Olson SH, Hogdall CK, Schwaab I, du Bois A, Harter P, Flanagan JM, Brown R, Paul J, Ekici AB, Beckmann MW, Hein A, Eccles D, Lurie G, Hays LE, Bean YT, Pejovic T, Goodman MT, Campbell I, Fasching PA, Konecny G, Kaye SB, Heitz F, Hogdall E, Bandera EV, Chang-Claude J, Kupryjanczyk J, Wentzensen N, Lambrechts D, Karlan BY, Whittemore AS, Culver HA, Gronwald J, Levine DA, Kjaer SK, Menon U, Schildkraut JM, Pearce CL, Cramer DW, Rossing MA, Chenevix-Trench G; AOCS group; ACS, Pharoah PD, Gayther SA, Ness RB, Odunsi K, Sucheston LE, Knutson KL, Goode EL. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res. 2014;2(4):332-40.
Akers SN, Moysich K, Zhang W, Collamat Lai G, Miller A, Lele S, Odunsi K, Karpf AR. LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecol Oncol. 2014;132(2):462-7.
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeny LA, Baglietto L, Giles GG, Severi G, Trabert B, Wentzensen N, Chenevix-Trench G, Whittemore AS, Sieh W, Chang-Claude J, Bandera EV, Orlow I, Terry K, Goodman MT, Thompson PJ, Cook LS, Rossing MA, Ness RB, Narod SA, Kupryjanczyk J, Lu K, Bützow R, Dork T, Pejovic T, Campbell I, Le ND, Bunker CH, Bogdanova N, Runnebaum IB, Eccles DM, Paul J, Wu AH, Gayther SA, Hogdall E, Heitz F, Kaye SB, Karlan BY, Anton-Culver H, Gronwald J, Hogdall CK, Lambrechts D, Fasching PA, Menon U, Schildkraut J, Pearce CL, Levine DA, Kruger Kjær S, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Song H, Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A, Lubinski J, Nevanlinna H, Bean YT, Lurie G, Ziogas A, Walsh C, Despierre E, Brinton L, Hein A, Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer J, Vitonis AF, Brooks-Wilson A, Aben KK, Pike MC, Ramus SJ, Wik E, Cybulski C, Lin J, Sucheston L, Edwards R, McGuire V, Lester J, du Bois A, Lundvall L, Wang- Gohrke S, Szafron LM, Lambrechts S, Yang HP, Beckmann MW, Pelttari LM, van Altena AM, Van Den Berg D, Halle M, Gentry-Maharaj A, Schwaab I, Chandran U, Menkiszak J, Ekici AB, Wilkens LR, Leminen A, Modugno F, Friel G, Rothstein JH, Vergote I, Garcia-Closas M, Hildebrandt MA, Sobiczewski P, Kelemen LE, Pharoah PD, Moysich K, Knutson KL, Cunningham JM, Fridley BL, Goode EL. Risk of Ovarian Cancer and the NF-κB Pathway: Genetic association with IL1A and TNFSF10. Cancer Res. 2014;74(3):852-61.
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N, Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kjær SK, Høgdall CK, Høgdall E, Lundvall L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Garcia- Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, Cook LS, Le ND, Brooks-Wilson A; On behalf of the Ovarian Cancer Association Consortium. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014;133(5):481-97. [Epub 2013 Nov 5]
Sieh W, Köbel M, Longacre TA, Bowtell DD, Defazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L,Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix- Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol. 2013;14(9):853-62
Godoy H, Mhawech-Fauceglia P, Beck A, Miliotto A, Miller A, Lele S, Odunsi K. Developmentally Restricted Differentiation Antigens Are Targets for Immunotherapy in Epithelial Ovarian Carcinoma. Int J Gynecol Pathol. 2013;(6):536-540.
Simpson-Abelson MR, Loyall JL, Lehman HK, Barnas JL, Minderman H, O'Loughlin KL, Wallace PK, George TC, Peng P, Kelleher RJ Jr, Odunsi K, Bankert RB. Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF- κB and NFAT signaling in tumor-associated T cells. Cancer Immun. 2013;Jul 15;13:14.
Janetzki S, Hoos A, Melief CJ, Odunsi K, Romero P, Britten CM. Structured reportingof T cell assay results. Cancer Immun. 2013 Jul 15;13:13.
James SR, Cedeno CD, Sharma A, Zhang W, Mohler JL, Odunsi K, Wilson EM, Karpf AR. DNA methylation and nucleosome occupancy regulate the cancer germline antigengene MAGEA11. Epigenetics. 2013;8(8):849-63.
Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, Kolls JK, Odunsi K, Billiar TR, Kalinski P. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Medicine. 2013;210(7):1433-445.
Yokota SJ, Facciponte JG, Kelleher RJ Jr, Shultz LD, Loyall JL, Parsons RR, Odunsi K, Frelinger JG, Lord EM, Gerber SA, Balu-Iyer SV, Bankert RB. Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model. Cancer Immun. 2013 May 31;13:11.
McNeil LK, Price L, Britten CM, Jaimes M, Maecker H, Odunsi K, Matsuzaki J, Staats JS, Thorpe J, Yuan J, Janetzki S. A Harmonized Approach to Intracellular Cytokine Staining Gating: Results from an International Multiconsortia Proficiency Panel Conducted by the Cancer Immunotherapy Consortium (CIC/CRI). Cytometry Part A. Aug;83(8):728-38.
Goode EL, Derycke M, Kalli KR, Oberg AL, Cunningham JM, Maurer MJ, Fridley BL, Armasu SM, Serie DJ, Ramar P, Goergen K, Vierkant RA, Rider DN, Sicotte H, Wang C, Winterhoff B, Phelan CM, Schildkraut JM, Weber RP, Iversen E, Berchuck A, Sutphen R, Birrer MJ, Hampras S, Preus L, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Song H, Tyrer J, Pharoah PP, Konecny G, Sellers TA, Ness RB, Sucheston LE, Odunsi K, Hartmann LC, Moysich KB, Knutson KL. Inherited variants in regulatory T cell genes and outcome of ovarian cancer. PLoS One. 2013;8(1):e53903.
Akers SN, Riebandt G, Miller A, Groman A, Odunsi K, Lele S. Bevacizumab for the treatment of recurrent ovarian cancer: A retrospective cohort study. Eur J Gyn Oncol. 2013;34(2):113-119.
Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of Quality Measures in Gynecologic Oncology Programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An Early Glimpse into a Challenging Initiative. Gynecol Oncol. 2013 May 26. [Epub ahead of print]
Ayyoub M, Pignon P, Classe JM, Odunsi K, Valmori D. CD4+ T Effectors Specific for the Tumor Antigen NY-ESO-1 Are Highly Enriched at Ovarian Cancer Sites and Coexist with, but Are Distinct from, Tumor-Associated Treg. Cancer Immunol Res. 2013;1(5):303-8
Budzinski EE, Patrzyc HB, Dawidzik JB, Freund HG, Frederick P, Godoy HE, Voian NC, Odunsi K, Box HC. Pyrimidine base damage is increased in women with BRCA mutations. Cancer Lett. 2013;338(2):267-70.
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Kobel M, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Ling Woo Y, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Palmieri Weber R, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Anne Rossing M, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Zawiah Omar S, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Mat Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubinski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kruger Kjaer S, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Hogdall CK, Hogdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Durst M, du Bois A, Dork T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Leigh Pearce C. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 2013;4:1628.
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J, Dicks E, Aben KK, Anton-Culver H, Antonenkova N, Armasu SM, Baglietto L, Bandera EV, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brenton JD, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Campbell I, Carney ME, Carvalho RS, Chang-Claude J, Chen YA, Chen Z, Chow WH, Cicek MS, Coetzee G, Cook LS, Cramer DW, Cybulski C, Dansonka- Mieszkowska A, Despierre E, Doherty JA, Dork T, du Bois A, Durst M, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher D, Flanagan J, Gao YT, Garcia- Closas M, Gentry-Maharaj A, Giles G, Gjyshi A, Gore M, Gronwald J, Guo Q, Halle MK, Harter P, Hein A, Heitz F, Hillemanns P, Hoatlin M, Hogdall E, Hogdall CK, Hosono S, Jakubowska A, Jensen A, Kalli KR, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Konecny GE, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee N, Lee J, Leminen A, Lim BK, Lissowska J, Lubinski J, Lundvall L, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson S, Orlow I, Paul J, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Qu X, Risch HA, Rodriguez-Rodriguez L, Rossing MA, Rudolph A, Runnebaum I, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shridhar V, Shu XO, Sieh W, Southey MC, Spellman P, Tajima K, Teo SH, Terry KL, Thompson PJ, Timorek A, Tworoger SS, van Altena AM, van den Berg D, Vergote I, Vierkant RA, Vitonis AF, Wang- Gohrke S, Wentzensen N, Whittemore AS, Wik E, Winterhoff B, Woo YL, Wu AH, Yang HP, Zheng W, Ziogas A, Zulkifli F, Goodman MT, Hall P, Easton DF, Pearce CL, Berchuck A, Chenevix-Trench G, Iversen E, Monteiro AN, Gayther SA, Schildkraut JM, Sellers TA. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 2013;45(4):362.
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Ann Chen Y, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM, Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang-Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek MS, Coetzee GA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dork T, du Bois A, Durst M, Easton DF, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher DA, Flanagan JM, Garcia-Closas M, Gentry-Maharaj A, Giles GG, Glasspool RM, Gonzalez-Bosquet J, Goodman MT, Gore M, Gorski B, Gronwald J, Hall P, Halle MK, Harter P, Heitz F, Hillemanns P, Hoatlin M, Hogdall CK, Hogdall E, Hosono S, Jakubowska A, Jensen A, Jim H, Kalli KR, Karlan BY, Kaye SB, Kelemen LE, Kiemeney LA, Kikkawa F, Konecny GE, Krakstad C, Kruger Kjaer S, Kupryjanczyk J, Lambrechts D, Lambrechts S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Kiong Lim B, Lin J, Lissowska J, Lu KH, Lubinski J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Raska P, Renner SP, Risch HA, Rodriguez-Rodriguez L, Anne Rossing M, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shridhar V, Shu XO, Shvetsov YB, Sieh W, Song H, Southey MC, Spiewankiewicz B, Stram D, Sutphen R, Teo SH, Terry KL, Tessier DC, Thompson PJ,Tworoger SS, van Altena AM, Vergote I, Vierkant RA, Vincent D, Vitonis AF, Wang- Gohrke S, Palmieri Weber R, Wentzensen N, Whittemore AS, Wik E, Wilkens LR, Winterhoff B, Ling Woo Y, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Phelan CM, Iversen E, Schildkraut JM, Berchuck A, Fridley BL, Goode EL, Pharoah PD, Monteiro AN, Sellers TA, Gayther SA. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 2013;4:1627.
Mach CM, Kim J, Soibam B, Creighton CJ, Hawkins SM, Zighelboim I, Goodfellow P, Gunaratne PH, Odunsi K, Salem PA, Anderson ML. Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas. Cancer letters. 2013;335(2):314.
Faber MT, Kjaer SK, Dehlendorff C, Chang-Claude J, Andersen KK, Hogdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control: CCC. 2013; 24(5):989.
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F, Vergote I, Lambrechts S, Despierre E, Risch HA, Gonzalez-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H, Konecny GE, Lambrechts D, Rogmann L, Guenel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, Haiman CA, Wang-Gohrke S, Andrulis IL, Moysich KB, Hopper JL, Odunsi K, Lindblom A, Giles GG, Brenner H, Simard J, Lurie G, Fasching PA, Carney ME, Radice P, Wilkens LR, Swerdlow A, Goodman MT, Brauch H, Garcia-Closas M, Hillemanns P, Winqvist R, Durst M, Devilee P, Runnebaum I, Jakubowska A, Lubinski J, Mannermaa A, Butzow R, Bogdanova NV, Dork T, Pelttari LM, Zheng W, Leminen A, Anton-Culver H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman M, Yatabe Y, Hamann U, Karlan BY, Sangrajrang S, Kjaer SK, Gaborieau V, Jensen A, Eccles D, Hogdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben R, Omar SZ, Czene K, Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Terry KL, Fletcher O, Vitonis AF, van der Schoot CE, Poole EM, Hogervorst FB, Tworoger SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow I, Blomqvist C, Rodriguez-Rodriguez L, Aittomaki K, Salvesen HB, Muranen TA, Wik E, Brouwers B, Krakstad C, Wauters E, Halle MK, Wildiers H, Kiemeney LA, Mulot C, Aben KK, Laurent-Puig P, Altena AM, Truong T, Massuger LF, Benitez J, Pejovic T, Perez JI, Hoatlin M, Zamora MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, Le ND, Sohn C, Brooks-Wilson A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, Hogdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, den Ouweland AM, Brown R, Martens JW, Flanagan JM, Kriege M, Paul J, Margolin S, Siddiqui N, Severi G, Whittemore AS, Baglietto L, McGuire V, Stegmaier C, Sieh W, Muller H, Arndt V, Labreche F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, Ziogas A, Ashworth A, Gentry-Maharaj A, Jones M, Ramus SJ, Orr N, Menon U, Pearce CL, Bruning T, Pike MC, Ko YD, Lissowska J, Figueroa J, Kupryjanczyk J, Chanock SJ, Dansonka-Mieszkowska A, Jukkola-Vuorinen A, Rzepecka IK, Pylkas K, Bidzinski M, Kauppila S, Hollestelle A, Seynaeve C, Tollenaar RA, Durda K, Jaworska K, Hartikainen JM, Kosma VM, Kataja V, Antonenkova NN, Long J, Shrubsole M, Deming-Halverson S, Lophatananon A, Siriwanarangsan P, Stewart-Brown S, Ditsch N, Lichtner P, Schmutzler RK, Ito H, Iwata H, Tajima K, Tseng CC, Stram DO, van den Berg D, Yip CH, Ikram MK, Teh YC, Cai H, Lu W, Signorello LB, Cai Q, Noh DY, Yoo KY, Miao H, Iau PT, Teo YY, McKay J, Shapiro C, Ademuyiwa F, Fountzilas G, Hsiung CN, Yu JC, Hou MF, Healey CS, Luccarini C, Peock S, Stoppa-Lyonnet D, Peterlongo P, Rebbeck TR, Piedmonte M, Singer CF, Friedman E, Thomassen M, Offit K, Hansen TV, Neuhausen SL, Szabo CI, Blanco I, Garber J, Narod SA, Weitzel JN, Montagna M, Olah E, Godwin AK, Yannoukakos D, Goldgar DE, Caldes T, Imyanitov EN, Tihomirova L, Arun BK, Campbell I, Mensenkamp AR, van Asperen CJ, van Roozendaal KE, Meijers-Heijboer H, Collee JM, Oosterwijk JC, Hooning MJ, Rookus MA, van der Luijt RB, Os TA, Evans DG, Frost D, Fineberg E, Barwell J, Walker L, Kennedy MJ, Platte R, Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B, Damiola F, Faivre L, Frenay M, Sinilnikova OM, Caron O, Giraud S, Mazoyer S, Bonadona V, Caux-Moncoutier V, Toloczko-Grabarek A, Gronwald J, Byrski T, Spurdle AB, Bonanni B, Zaffaroni D, Giannini G, Bernard L, Dolcetti R, Manoukian S, Arnold N, Engel C, Deissler H, Rhiem K, Niederacher D, Plendl H, Sutter C, Wappenschmidt B, Borg A, Melin B, Rantala J, Soller M, Nathanson KL, Domchek SM, Rodriguez GC, Salani R, Kaulich DG, Tea MK, Paluch SS, Laitman Y, Skytte AB, Kruse TA, Jensen UB, Robson M, Gerdes AM, Ejlertsen B, Foretova L, Savage SA, Lester J, Soucy P, Kuchenbaecker KB, Olswold C, Cunningham JM, Slager S, Pankratz VS, Dicks E, Lakhani SR, Couch FJ, Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel RR, Goode EL, Greene MH, Easton DF, Berchuck A, Antoniou AC, Chenevix- Trench G, Dunning AM. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 2013;45(4):371.
Link PA, Zhang W, Odunsi K, Karpf AR. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer. Cancer Immunity. 2013;13:6.
Mhawech-Fauceglia P, Wang D, Ali L, Lele S, Huba MA, Liu S, Odunsi K. Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients. Cancer Immun. 2013;13:1.
Peng M, Bakke JL, DiCioccio RA,Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L. Inactivating mutation in GT198 in familial and early- onset breast and ovarian cancers. Genes Cancer. 2013;4(1-2):15-25.
Godoy H, Khan AN, Vethanayagam RR, Grimm MJ, Singel KL, Kolomeyevskaya N, Sexton KJ, Parameswaran A, Abrams SI, Odunsi K, Segal BH. Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice. PLoS One. 2013;8(7):e69631
Godoy H, Vaddadi P, Cooper M, Frederick PJ, Odunsi K, Lele S. Photodynamic therapy effectively palliates gynecologic malignancies. Eur J Gynaecol Oncol. 2013;34(4):300-2.
Olawaiye AB, Godoy HE, Shahzad MM, Rauh-Hain JA, Lele SB, Odunsi K. Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer. Eur J Gynaecol Oncol 2012;33(5):477-9.
Zhao H, Shen J, Wang D, Gregory S, Medico L, Hu Q, Yan L, Odunsi K, Lele S, Liu S Associations between Gene Expression Variations and Ovarian Cancer Risk Alleles Identified from Genome Wide Association Studies. PLoS One. 2013;8(5).
Odunsi K, Mhawech-Fauceglia P, Andrews C, Beck A, Amuwo O, Lele S, Black JD, Huang R-Y. Elevated expression of the Serine-Arginine Protein Kinase 1 gene in Ovarian Cancer and its Role in Cisplatin Cytotoxicity in vitro. PLoS ONE. 2012;7(12):e51030
Obermajer N, Wong JL, Edwards RP, Odunsi K, Moysich K, Kalinski P. PGE(2)- Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells. Immunol Invest. 2012;41(6-7):635-57.
Akers S, Groman A, Odunsi K, Lele S, Frederick P. Adjuvant treatment for unterine leiomyoscaroma. In Press. Eur J Gyn Oncol.
Hampras SS, Nesline M, Wallace PK, Odunsi K, Furlani N, Davis W, Moysich KB. Predictors of immunosuppressive regulatory T lymphocytes in healthy women. J Cancer Epidemiol. 2012;2012:191090.
Berinstein NL, Karkada M, Morse MA, Nemunaitis JJ, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, Macdonald LD, Weir GM, Stanford MM, Mansour M. First- in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J Transl Med. 2012;10(1):156.
Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff TH, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM. T Cell Assays and MIATA: The Essential Minimum for Maximum Impact. Immunity. 2012;27;37(1):1-2.
Sirugo G, Edwards DR, Ryckman K, Bisseye C, White, M, Kebbeh B, Morris G, Adegbola R, Tacconelli A, Predazzi I, Novelli G, Vannberg F, Odunsi K, Page G, Williams SM. PTX3 genetic variation and dizygotic twinning in The Gambia: could pleiotropy with innate immunity explain common dizygotic twinning in Africa? Ann Hum Genet. 2012;76(6):454-463.
Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res. 2012;72(17):4351.
Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Ambrosone CB, O'Connor, TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K. NY- ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer. PLoS One. 2012;7(6):e38783.
Kim KM, Song MH, Kim MJ, Daudi S, Miliotto A, Old L, Odunsi K, Lee SY. A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation. Int J Oncol. 2012;41(3):1139-47.
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho, LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455-65.
Shan W, Akinfenwa PY, Savannah KB, Kolomeyevskaya N, Laucirica R, Thomas DG, Odunsi K, Creighton CJ, Lev DC, Anderson ML. A small molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. Clin Cancer Res. 2012;18(12):3352-65.
Qian F, Liao J, Villella J, Edwards R, Kalinski P, Lele S, Shrikant P, Odunsi K. Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2 mediated arrest of human T cell proliferation. Cancer Immunol Immunother. 2012;61(11):2013- 20. PMID:22527253
Odunsi K, Matsuzaki J, Karbach J. Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison C, Ritter G, Godoy H, Lele S, duPont N, Edwards R, Shrikant P, Old LJ, Gnjatic S, Jager E. Efficacy of vaccination with recombinant vaccina and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci U S A. 2012; 109 (15) 5797-5802.
Tsuji, T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S. Heat Shock Protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4+ T cells. J Immunol. 2012;188(8):3851-8.
Li Q, Rao R, Vazzana J, Goedegeburre P, Odunsi K, Gillanders W, Shrikant PA. Regulation mammalian target of rapamycin to tune vaccination-induced CD8+ T cell responses for tumor immunity. J Immunol. 2012;188(7):3080.
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Gorski B, Osorio A, Duran M, Tejada MI, Benitez J, Hamann U, Hogervorst FB, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MG, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE, Bove B, Godwin AK, Stoppa-Lyonnet D, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK,Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz MD, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene
MH, Mai PL, Easton DF, Chenevix-Trench G, Offit K, Simard J. Common Variants at
the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiol Biomarkers Prev. 2012;21(4):645-57.
Shen J, Wang D, Gregory S, Medico L, Hu Q, Yan L, Odunsi K, Lele SB, Ambrosone CB, Liu S, Zhao H. Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer. Carcinogenesis. 2012; 33(3):604-12.
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano, AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B,Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler- Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de Al Hoya M, Canadas C, Heikkinen T, Heikkila , Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor, NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen S. L, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012;21(1):134-147.
Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, Rosenquist R, Karlsson P, Nathanson K, Domchek S, Rebbeck T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka-Perlowska E, Osorio A, Duran M, Andres R, Benitez J, Hamann U, Hogervorst FB, T A.v.O., Verhoef S, Meijers-Heijboer HE, Wijnen J, Gomez Garcia EB, Ligtenberg MJ, Kriege M, Collee JM, Ausems MG, Oosterwijk JC, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Rogers MT, Donaldson A, Dorkins H, Godwin AK, Bove B, Stoppa-Lyonnet D, Houdayer C, Buecher , de Pauw A, Mazoyer S, Calender A, Leone M, Bressac-de Paillerets B, Caron O, Sobol H, Frenay M, Prieur F, Fert Ferrer S, Mortemousque I, Buys S, Daly M, Miron A, Terry MB, Hopper JL, John EM, Southey M, Goldgar D, Singer CF, Fink-Retter A, Tea MK, Geschwantler Kaulich D, Hansen TV, Nielsen FC, Barkardottir RB, Gaudet M, Kirchhoff T, Joseph V, Dutra-Clarke A, Offit K, Piedmonte M, Kirk J, Cohn D, Hurteau J, Byron J, Fiorica J, Toland AE, Montagna M, Oliani C, Imyanitov E, Isaacs C, Tihomirova L, Blanco I, Lazaro C, Teule A, Del Valle J, Gayther SA, Odunsi K, Gross J, Karlan BY, Olah E, Teo SH, Ganz PA, Beattie MS, Dorfling CM, Jansen van Rensburg E, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schafer D, Caldes T, de la Hoya M, Nevanlinna H, Muranen TA, Lesperance B, Spurdle AB, Neuhausen SL, Ding YC, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Loud JT, Andrulis IL, Ozcelik H, Mulligan AM, Glendon G, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Chenevix-Trench G, Couch FJ, Simard J, Easton DF, Swedish Breast Cancer Study SB, Research Facility H, Study E, Study Collaborators G, Investigators K. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res, 2012;14(1): R33.
Mhawech-Fauceglia P, Wang D, Syriac S, Godoy H, Dupont N, Liu S, Odunsi K.
Synuclein-gamma (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma. Gynecol Oncol. 2012;124(1):148-52.
Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Hakansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Nelief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ., Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML. Defining the Critical Hurdles in Cancer Immunotherapy. J Transl Med. 2011;(9)1:214.
Obermajer N, Muthuswamy R, Odunsi K, Edwards R, Kalinski P. PGE2-Dependent CXCL12 Production and CXCR4 Expression Control the Accumulation of Human MDSCs in Ovarian Cancer Environment. Cancer Res. 2011;71(24):7463-70.
Agnani D, Camacho-Vanegas O, Camacho C, Lele S, Odunsi K, Cohen S, Dottino P, Martignetti JA. Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. J Ovarian Res. 2011; 4(1):18.
Mhawech-Fauceglia P, Wang D, Kesterson J, Beck A, de Mesy Bentley KL, Shroff S, Syriac S, Frederick PJ, Liu, Odunsi K. Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology. Histopathology. 2011;59(5):1015-8.
Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S. Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. PLoS One. 2011. 6(8): e23651.
Attig S, Price L, Janetzki S, Kalos M, Pride M, McNeil L, Clay T, Yuan J, Odunsi K, Hoos A, Romero P, Britten CM, Assay Working Group CC. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols. J Transl Med. 2011; 9(1):108.
Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J, Mi S, O'Donnell PFraiman YS, Das S, Cox NJ, Lu Y, Macgregor S, Goode EL, Vierkant RA, Fridley BL, Hogdall EV, Kjaer SK, Jensen A, Moysich KB, Grasela M, Odunsi KO, Brown R, Paul J, Lambrechts D, Despierre E, Vergote I, Gross J, Karlan BY, Defazio A, Chenevix-Trench G, Dolan ME. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res. 2011;17(16):5490-500.
Li Q, Rao RR, Araki K, Pollizzi K, Odunsi K, Powell JD, Shrikant PA. A Central Role for mTOR Kinase in Homeostatic Proliferation Induced CD8(+) T Cell Memory and Tumor Immunity. Immunity. 2011;34(4):541-53.
Woloszynska-Read A , Zhang W, Yu J , Link PA , Mhawech-Fauceglia P, Collamat G, Akers SN, Ostler KR, Godley LA , Odunsi KO, Karpf AR. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res. 2011;17:2170-80.
Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S. Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity. J Immunol. 2011:186;1218-27.
Bankert RB, Balu-Iyer SV, Odunsi K, Shultz LD, Kelleher RJ, Jr, Barnas JL, Simpson-Abelson M, Parsons R, Yokota SJ. Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One. 2011. 6(9): e24420.
Godoy H, Mhawech-Fauceglia P, Beck A, Miller A, Lele S, Odunsi K. Expression of Poly (Adenosine Diphosphate-Ribose) Polymerase and p53 in Epithelial Ovarian Cancer and Their Role in Prognosis and Disease Outcome. Int J Gynecol Pathol. 2011;30:139-44.
Garcia E, Andrews C, Hua J, Kim H, Sukumaran DK, Szyperski TA, Odunsi K. Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum exploredby use of a micro-flow NMR probe. J Proteome Res. 2011 Apr 1;10(4):1765-71.
Britten CM, Janetzki S, van der Burg SH, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM. Minimal information about T cell assays: the process of reachingthe community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother. 2011;60:15-22.
Mhawech-Fauceglia P, Wang D, Kesterson J, Clark K, Monhollen L, Odunsi K, Lele S, Liu S. Microarray analysis reveals distinct gene expression profiles among differenttumor histology, stage and disease outcomes in endometrial adenocarcinoma. PLoS One. 2010;5:e15415.
Caballero OL, Zhao Q, Rimoldi D, Stevenson BL, Svobodová S, Devalle S, Röhrig UF, Pagotto A, Michielin O, Speiser D, Wolchok JD, Liu C, Pejovic T, Odunsi K, Brasseur F, Van den Eynde BJ, Old LJ, Lu X, Cebon J, Strausberg RL, Simpson AJ. Frequent MAGE mutations in human melanoma. PLoS One. 2010;5:e12773.
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brook-Wilson A, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre E, Fasching PA, Beckmann MW, Thiel FC, Ekici AB, Chen X; the Australian Ovarian Cancer Study Group; the Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PD, Gayther SA. Commonvariants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010;42:880-4
Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant P, Old LJ, Odunsi K. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A. 2010;107:7875-80.
Gnjatic S, Ritter E, Büchler M, Giese N, Brors B, Frei C, Murray A, Halama N, Zörnig I, Chen Y-T, Andrews A, Ritter G, Old L, Odunsi K, Jäger D. Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A. 2010;107:5088-93.
Wadle A, Mischo A, Strahl S, Nishikawa H, Held G, Neumann F, Wullner B, Fischer E, Kleber S, Karbach J, Jager E, Shiku H, Odunsi K, Shrikant PA, Knuth A, Cerundolo V, Renner C. NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses. Yeast. 2010; 27:919-31.
Woloszynska-Read A, James SR, Song C, Jin B, Odunsi K, Karpf AR. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Cancer Immun. 2010;10:6.
duPont NC, Guru KA, Iskander GB, Odunsi K, Lele S, Rodabaugh K. Instituting a robot-assisted surgery programme at a tertiary cancer care center. Int J Med Robot. 2010 Sep;6(3):330-3.
Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory cell fate of CD8+ T cells by regulating T-bet and eomesodermin expression Immunity. 2010;32:67-78.
Mhawech-Fauceglia P, Herrmann RF, Kesterson J, Izevbaye I, Lele S, Odunsi K. Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. Eur J Surg Oncol. 2010 Dec;36:1195-201.
Mhawech-Fauceglia P, Herrmann FR, Rai H, Tchabo N, Lele S, Izevbaye I, Odunsi K, Cheney RT. IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma. Am J Clin Pathol. 2010;133:899-908.
Kesterson J, Odunsi K, Lele S. High Cumulative Doses of Pegylated Liposomal Doxorubicin Are Not Associated with Cardiac Toxicity in Patients with Gynecologic Malignancies. Chemotherapy. 2010 Apr 20;56(2):108-111.
Batt R, Mhawech-Fauceglia P, Odunsi K, Yeh J. Pathogenesis of mediastinal paravertebral müllerian cysts of Hattori: Developmental endosalpingiosis - Müllerianosis. Int J Gynecol Pathol. 2010 Nov;29:546-51.
Cheng L, Lu W, Kulkarni B, Pejovic T, Yan X, Chiang J-H, Hood L, Odunsi K, Lin B. Analysis of chemotherapy response programs in ovarian cancers by the next generation sequencing technologies. Gynecol Oncol. 2010;117:159-69.
Paczos TA, Ackers S, Odunsi K, Lele S, Mhawech-Fauceglia P. Primary Vaginal Adenocarcinoma Arising in Vaginal Adenosis After CO2 Laser Vaporization and 5- Fluorouracil Therapy. Int J Gynecol Pathol. 2010;29:193-6.
Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer. 2010;10:47.
Akers S, Odunsi K, Karpf AR. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future Oncology 2010;6:717-32.
Ferchichi, I., Stambouli, N., Marrackchi, R., Arlot, Y., Prigent, C., Fadiel, A., Odunsi, K., Ben Ammar Elgaaied, A., Hamza, A. Experimental and Computational Studies Indicate Specific Binding of pVHL Protein to Aurora-A Kinase. J Phys Chem B. 2010;14: 1486-97.
Li Q, Eppolito C, Odunsi K, Shrikant P. Antigen induced Erk1/2 activation regulates Ets-1 mediated sensitization of CD8+ T cells for IL-12 responses. J Leukoc Biol. 2010;87:257-63.
McCloskey S, Tchabo N, Malhotra H, Odunsi K, Rodabaugh K, Singhal P, Lele S, Jaggernauth W. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol. 2010;116:404-7.
Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, Mongoue- Tchokote S, Dim D, Andrews C, Beck A, Tarumi Y, Djilas J, Cappuccini F, Caballero O, Huang J, Levy S, Tsiamouri A, Cain J, Bagby G, Strausberg R, Simpson AJ, Odunsi K.Expression Profiling of the Ovarian Surface Kinome Reveals Candidate Genes for Early Neoplastic Changes. Transl Oncol 2009;2:341-9.
Tchabo NE, Mhawech-Fauceglia P, Caballero OL, Villella J, Beck A, Miliotto AJ, Liao J, Andrews C, Lele S, Old LJ, Odunsi K. Expression and serum immunoreacitivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer Immun. 2009;9:6.
Qian F, Villella J, Wallace PK, Mhawech-Fauceglia P, Tario, Jr. JD, Andrews C, Matsuzaki J, Valmori D, Ayyoub M, Frederick PJ, Beck A, Liao J, Cheney R, Moysich K, Lele S, Shrikant P, Old LJ, Odunsi K. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T- cell proliferation in human epithelial ovarian cancer. Cancer Research. 2009;69:5498-5504.
Leveque L, Deknuydrt F, Bioley G, Old L, Matsuzaki J, Odunsi K, Ayyoub M, Valmori D. Interleukin 2-mediated conversion of ovarian cancer associated CD4+ regulatory T cells into pro-inflammatory interleukin 17-producing helper T cells. J Immunother. 2009;32:101-108.
Tayo BO, DiCioccio RA, Liang Y, Trevisan M, Cooper RS, Lele S, Sucheston L, Piver SM, Odunsi K. Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance. PloS ONE. 2009;4:e5939.
Simpson-Abelson MR, Purohit VS, Pang WM, Iyer V, Odunsi K, Demmy TL, Yokota SJ, Loyall JL, Kelleher Jr. RJ, Balu-Iyer S, Bankert RB. IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments. Clinical Immunol. 2009;132:71-82.
Lin B, White JT, Wu J, Lele S, Old LJ, Hood L, Odunsi K. Deep depletion of abundant serum proteins reveals low abundant proteins as biomarker for human ovarian cancer. Proteomics Clin App, 2009;3:853-61.
Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old LJ, Hoos A, Romero P. for the HLA-peptide Multimer Proficiency panel of the CVC-CRI Immune Assay Working Group. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium (CVC). Cancer Immunol Immunother. 2009;58:1701-13.
Chen YT, Hsu M, Lee P, Shin SJ, Mhawech-Fauceglia P, Odunsi K, Altorki NK, Song CJ, Jin BQ, Simpson AJ, Old LJ. Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer. Int J Cancer. 2009;124:2893-8.
Mhawech-Fauceglia P, Herrmann FR, Wagner H, Godoy H, Odunsi K, Cheney RT, Lele S. Submission of the entire lymph node dissection for histologic examination in gynecologic-oncology specimens. Gynecol Oncol. 2009;115:354-6.
Sukumaran D, Garcia E, Hua J, Tabaczynski W, Odunsi K, Andrews C, Szyperski T. Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H-NMR micro-flow probe. Magn Reson Chem. 2009; 47, S81–S85.
Tchabo NA, McCloskey S, Mashtare TL, Andrews C, Singh AK, Odunsi K, Lele S, Jaggernauth W. Treatment of early stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Gyne Onc. 2009;115:249-256.
Mhawech-Fauceglia P, Herrmann FR, Andrews C, South S, Beck A, Lele S, Odunsi K.14-3-3б Expression and prognostic value in patients with epithelial ovarian carcinoma: A high throughput tissue microarray analysis. Eur J Surg Oncol. 2009;35:763-7.
Rai H, Odunsi K, Kesterson J, Morrison C, Chan A, Mhawech-Fauceglia P. Epithelioid sarcoma of the vulva in a 17-year-old pregnant woman. Appl Immunohistochem Mol Morphol. 2009;17:270-273.
Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A. 2008;105:15505-10.
Tosello V, Odunsi K, Souleimanian NE, Lele S, Shrikant P, Old LJ, Valmori D, Ayyoub M. Differential expression of CCR7 defines two distinct subsets of human memory CD4(+)CD25(+) Tregs. Clin Immunol. 2008;126:291-302.
Woloszynska-Read A, Mhawech-Fauceglia P, Yu J, Odunsi K, Karpf A. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clin Cancer Res. 2008;14:3283- 90.
Yin B, Kiyamova R, Chua R, Caballero OL, Gout I, Gryshkova V, Bhaskaran N, Souchelnytskyi S, Hellman U, Filonenko V,. Jungbluth AA, Odunsi K, Lloyd KO, Old LJ, Ritter G. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas; a new target for cancer immunotherapy. Cancer Immunity. 2008;8:3.
Mhawech-Fauceglia P, Smiraglia DJ, Bshara W, Andrews C, Schwaller J, South S, Higgs D, Lele S, Herrmann F, Odunsi K. Prostate-Specific Membrane Antigen expression is a potential prognostic marker in endometrial adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:571-7.
Mhawech-Fauceglia P, Odunsi K, Dim D, Nowak N, Lele S, Cheney RT, Pejovic, T. Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: Mystery resolved? Int J Gynecol Pathol. 2008;27:539-46.
Mhawech-Fauceglia P, Allal A, Odunsi K, Andrews C, Herrmann FR, Huard B. Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer. 2008; 44:2097-100.
Shen J, Ambrosone CB, Dicioccio R, Odunsi K, Lele SB, Zhao H. A Functional Polymorphism in the miR-146a Gene and Age of Familial Breast/Ovarian Cancer Diagnosis. Carcinogenesis. 2008;29:1963-6.
Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer Immunol Immunother. 2008;57(8):1185-95.
Ghadersohi A, Odunsi K, Fayazi Z, Zhang S, Azruk RG, Bundy BN, Manjili MH, Rustum YM, Li F. Prostate-derived Ets transcription Factor as a favorable prognostic marker on ovarian cancer patients. Int J Cancer. 2008;123:1376-84.
Mhawech-Fauceglia P, Pejovic T, Dim D, Fang X, Conroy J, Lele S, Cheney R, Odunsi K. Array-based comparative genomic hybridization (aCGH) analysis is a useful tool for distinguishing primary pulmonary from metastatic neuroendocrine carcinoma to the lung. Appl Immunohistochem Mol Morphol. 2008;16:291-295.
Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, Odunsi K. The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus. Histopathology. 2008;53:490-495.
Mhawech-Fauceglia P, Herrman F, Bshara W, Zhang S, Penetrante R, Lele S, Odunsi K, Rodabaugh K. Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings. Int J Gynecol Path. 2008;27:431-6.
Woloszynska-Read A, James SR, Link PA, Yu J, Odunsi K, Karpf AR.DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer Immun. 2007 Dec 21;7:21.
Odunsi K, Qian F, Matsuzaki J, Mhawech-Fauceglia P, Andrews C, Hoffman EW, Pan L, Ritter G, Villella J, Thomas B, Rodabaugh K, Lele S, Shrikant P, Old LJ, Gnjatic S. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T-cell responses in ovarian cancer. Proc Natl Acad Sci U S A. 2007;104:12837-42.
Sharma S, Tammela J, Wang X, Arnouk H, Driscoll D, Mhawech-Fauceglia P, Lele S, Kazim AL, Odunsi K. Characterization of a Putative Ovarian Oncogene, Elongation Factor 1{alpha}, Isolated by Panning a Synthetic Phage Display Single-Chain Variable Fragment Library with Cultured Human Ovarian Cancer Cells. Clin Cancer Res. 2007;13:5889-96.
Aikhionbare FO, Mehrabi S, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007 26;6(1):1.
Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K,Beehler GP, Zirpoli G, McCann SE, Villella JA. Usual Adult Body Mass Index is Not Predictive of Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2007;16:626-8.
Shamshirsaz AA, Withiam-Leitch M, Odunsi K, Baker T, Frederick P, Lele S. Young patients with endometrial carcinoma selected for conservative treatment: A need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol. 2007;104:757-60.
Li Q, Eppolito C, Odunsi K, Shrikant P. IL-12-Programmed long-term CD8+ T responses require STAT4. J Immunol. 2006;177:7618-25.
Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M , Livingston P, Iosonos A, Spriggs D, McGuire W, Reinartz S, Schnieder S, Grande C, Lele S, Rodabaugh K , Kepner J, Ferrone S, Odunsi K. Phase I study of the antibody abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clin Cancer Res. 2006;12:5503-10.
Nishikawa H, Qian F, Tsuji T, Ritter G, Old LJ, Gnjatic S, Odunsi K. Influence of CD4+ CD25+ regulatory T cells on low/ high-avidity CD4+ T cells following peptide vaccination. J Immunol. 2006;176:6340-6.
Mhawech-Fauceglia P, Herrmann FR, Bshara W, Odunsi K, Terracciano L, Sauter G, Cheney RT, Groth J, Penetrante R, Mhawech-Fauceglia P. Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol. 2007;60(6):694-700.
Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gjnatic S, Stockert E; Driscoll D, Lele S, Old LJ, Odunsi K. Expression of SSX antigen in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ cells. Clin Cancer Res. 2006;12(2)398-404.
Mhawech-Fauceglia P, Herrmann F, Penetrante R, Beck A, Sait S, Block AM, Malik D, Odunsi K, Fisher J, Balos L, Cheney RT. Diagnostic Utility Of FLI-1 Monoclonal Antibody And Dual-Color, Break-Apart Probe Fluorescence In Situ (FISH) Analysis In Ewing’s Sarcoma/ Primitive Neuroectodermal Tumor (EWS/PNET) A comparative Study to CD99 and FL I-1Polyclonal Antibodies. Histopathology. 2006;49:569-75.
Collins Y, DiCioccio R, Keitz B, Lele S, Odunsi K. Methylation of Death Associated Protein (DAP) kinase in ovarian carcinomas. Int J Gynecol Cancer. 2006;16 (Suppl 1):195-9.
Hylander B, Repasky E, Shirkant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K. Expression of Wilm’s tumor gene (WT1) in epithelial ovarian cancer.. Gynecol Oncol. 2006;101(1):12-7.
Villella J, Herrmann FR, Kaul S, Lele S, Marchetti D, Natiella J, Odunsi K, Mhawech- Fauceglia P. Clinical and Pathologic Predictive Factors in Women with Adult-Type Granulosa Cell Tumor of the Ovary. Int J Gynecol Path. 2007;26:154-9.
Sharma S, Rezai K, Driscoll D, Odunsi K, Lele S. Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer. Gynecol Oncol. 2006;103:181-5.
Fischer G, Odunsi K, Lele S, Mhawech P. Ovarian primary primitive neuroctodermal tumor (PNET) co-existing with endometroid adenocarcinoma: A case report. Int J Gynecol Path. 2006;25:151-4.
Fisher D, Chen Q, Appenheimer M, Skitzki J, Wang W-C, Odunsi K, Evans S. Hurdles to Lymphocyte Trafficking in the Tumor Microenvironment: Implications for Effective Immunotherapy. Immunol Invest. 2006;35:251-77.
Singhal P, Odunsi K, Driscoll D, Rodabaugh K, Lele S. Primary fallopian tube carcinoma restrospective clinicopathologic study. Eur J Gynaec Oncol. 2006;27(1):16- 8.
Tammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth A, Mhawech-Fauceglia P, Qian F, Schneider S, Driscoll D, Lele S, Old L, Nakayama E, Odunsi K. OY-TES-1 Expression and Serum Immunoreactivity in Epithelial Ovarian Cancer. Int J Oncol. 2006;29:903- 10.
Kidd K, Pakstis A, Speed WC, Grigorenko E, Kajuna S, Karoma NJ, Kungulilo S, Kim J, Lu R, Odunsi K, Okonofua F, Parnas J, Schulz L, Zhukova O, Kidd J. Developing a SNP panel for forensic identification of individuals. Forensic Sci Int. 2006;164:20-32.
Sato E, Olson SH, Ahn J, Jungbluth AA, Frosina D, Bundy B, Qian F, Gnjatic S, Ambrosone C, Kepner J, Keitz B, Odunsi T., Ritter G, Lele S, Chen Y, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ Tumor infiltrating lymphocytes and high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005;102:18538-43
Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol. 2005;193:2077-82.
Han Y, Oota H, Osier MV, Pakstis AJ, Speed WC, Odunsi K, Okonofua F, Kajuna SLB, Nganyirwa, Karoma J, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Schulz LO, Kidd JR, Kidd KK. Considerable Haplotype Diversity within the 23kb Encompassing the ADH7 Gene. Alcohol Clin Exp Res. 2005:Dec;29(12):2091-2100.
Menakaya U, Otoide V, Agboja LO, Odunsi K, Okonofua F. Experience with misoprostol in the management of missed abortion in the second trimester. J Obstet Gynaecol. 2005;25:583-5.
Sharma S, Qian F, Driscoll D, Scanlan MJ, Skipper J, Rodabaugh KJ, Lele S, Old LJ, Odunsi K. A-kinase anchoring protein 3 messenger rna expression correlates with poor prognosis in epithelial ovarian cancer. Gynecol Oncol. 2005;99:183-8.
Odunsi K, Wollman R, Ambrosone C, Hutson A, McCann S, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Detection of epithelial ovarian cancer using 1H-NMR- based metabonomics. Int J Cancer. 2005;113:782-788.
Qian F, Odunsi K, Blatt L, Scanlan M, Mannan M, Shah N, Montgomery J, Haddad F, Taylor M. Tumor associated antigen recognition by autologous serum in patients with breast cancer. Int J Mol Med. 2005;15:137-144.
Sharma S, Odunsi K, Driscoll D, Lele S. Pelvic extenterations for gynecologic malagancies: 20 years experience at Roswell Park Cancer Institute. Int J Gynecol Cancer. 2005;15:475-482.
Singhal P, Spiegel G, Driscoll D, Odunsi K, Lele S, Rodabaugh K. Cyclooxygenase 2 expression in serous tumors of the ovary. Int J Gynecol Path. 2005;24:62-66.
Villella J, Marchetti D, Odunsi K, Rodabaugh K, Driscoll DL, Lele S. Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma. Gynecol Oncol. 2004;95:539-545.
Qian F, Gnjatic S, Jager E, Darren Santiago D, Jungbluth A, Grande C, Schneider S, Keitz B, Ritter G, Lele S, Sood A, Old LJ, Odunsi K. T Helper Type1 (Th1)/Th2 CD4+ Tcell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer. Cancer Immun. 2004;4:12.
Pejovic T, Ladner D, Intengan M, Zheng K, Fairchild T, Easley S, Dillon D, Marchetti D, Schwartz P, Lele S, Odunsi K. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur J Cancer. 2004;40:2519-2524.
Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan M, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. SCP-1 “Cancer / Testis” antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer. Cancer Immun. 2004; 4:10.
Collins Y, Tan DF, Pejovic T, Mor G, Rutherford T, Varma R, McQuaid D, Driscoll D, Jiang M, Deeb G, Lele S, Nowak N, Odunsi K. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. Int J Mol Med. 2004 Jul;14:43-53.
Olawaiye A, Caesar ML, Walsh D, Lyman M, Yeh J, Rodabaugh R, Marchetti D, Shashikant Lele S, Odunsi K. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers. Gynecol Oncol. 2004;94:796-802.
Oota H, Pakstis AJ, Bonne-Tamir B, Goldman D, Grigorenko E, Kajuna SL, Karoma NJ, Kungulilo S, Lu RB, Odunsi K, Okonofua F, Zhukova OV, Kidd JR, Kidd KK. The evolution and population genetics of the ALDH2 locus; random genetic drift, selection, and low levels of recombination. Ann Hum Genet. 2004;68:93-109.
Tammela J, Bundy B, Odunsi K. Reassessment of pelvic lymph node debulking in advanced cervical cancer. Gynecol Oncol. 2004;92:1014-1015.
Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Baker T, Marchetti D, Lele S. Efficacy of Adjuvant CYVADIC chemotherapy in early stage uterine sarcomas: results of long term follow-up. Int J Gynecol Cancer. 2004;14:659-664.
Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu R, Parnas J, Kidd JR, DeMille M, Kidd KK. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry. 2004;9:859-870.
dos Santos L, Odunsi K, Lele S. Clinicopathologic outcome of laser conization for high-grade cervical dysplasia. Eur J Gynaec Oncol. 2004;25:305-307.
Sirugo G, Ashenbrenner J, Odunsi K, Morakinyo O, Page G. No evidence of association between the genetic predisposition of dizygotic twinning and schizophrenia in West Africa. Schizophr Res. 2004;70:343-344
Ghadersohi A, Odunsi K, Lele S, Collins Y, Greco WR, Winston JS, Liang P, Sood AK. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules. Oncol Rep. 2004;11:453-58.
Odunsi K, Olatinwo M, Collins Y, Withiam-Leitch M, Lele S, Spiegel G. Primary primitive neuroectodermal tumor (PPNET) of the uterus: a report of 2 cases and review of the literature. Gynecol Oncol. 2004; 92:689-696.
Odunsi K, Jungbluth A, Stockert E, Qian F, Gnajtic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res. 2003;63:6076- 6083.
Chattopadhyay P, Pakstis AJ, Mukherjee N, Iyengar S, Odunsi K, Okonofua F, Bonne-Tamir B, Speed W, Kidd JR, Kidd KK. 2003. A global survey of haplotype frequencies and linkage disequilibrium at the RET locus. Eur J Hum Genet. 2003;11:760-769.
Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer. Int J Gynecol Cancer. 2003;13:142-147.
DeMille MC, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi K, Okonofua F, Grigorenko E, Schulz LO, Bonne-Tamir B, Lu RB, Parnas J, Pakstis AJ, Kidd KK. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet. 2002;111:521-537.
Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer. Am J Obstet Gynecol. 2002;187:575-580.
Osier MV, Pakstis AJ, Soodyall H, Comas D, Goldman D, Odunsi K, Okonofua F, Parnas J, Schulz L, Bertranpetit J, Bonne-Tamir B, Lu R, Kidd JR, Kidd K. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet. 2002;71:84-99.
Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastasis. Gynecol Oncol. 2002;85:487-492.
Odunsi K, Ganesan TS. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis. Int J Mol Med. 2001;8:405-412.
Odunsi K, Lele S, Ghamande S, Seago P, Driscoll D. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynecol Oncol. 2001;5:325-330.
Chandrasekaran EV, Chawda R, Piskorz C, Locke RD, Ta A, Ghamande S, Odunsi K, Lele S, Matta K. Human ovarian cancer, lymphoma spleen, and bovine milk GlcNac:1,4Gal/GalNac transferases: two molecular species in ovarian tumor and induction of GalNac1,4Glc synthesis by α-lactalbumin. Carbohydr Res. 2001;334:105- 118.
Odunsi K, Van Ee C, Ganesan TS, Shelling AN. Evaluation of the possible protective role of adeno-associated virus type II infection in HPV associated cervical neoplasia. Gynecol Oncol. 2000;78:342-345.
Kidd JR, Pakstis AJ, Ru-Band L, Okonofua FE, Odunsi K, Grigorenko E, Batsheva BT, Kidd KK. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus (PAH) in a global representation of populations. Am J of Hum Genet. 2000;66:1882-1889.
Odunsi K, Pejovic T, Savalgi R. Principles of evidence based screening for cancers. Surg Technol Int, IX. 2000;318-332.
Odunsi K, Kidd KK. A paradigm for finding genes for a complex human trait: Polycystic ovary syndrome and follistatin. Proc Nat Acad Sci, USA. 1999;96:8315- 8317.
Pejovic T, Burki N, Odunsi K, Fielder P, Achong N, Schwartz P, Ward DC. Well differentiated mucinous carcinoma of the ovary and a co-existing Brenner tumor both exhibit amplification of 12q14-21 by comparative genomic hybridization (CGH). Gynecol Oncol. 1999;74:134-137.
Johns BJ, Odunsi K, Fleischman S, Azodi M, Schwartz P. Serous adenocarcinoma of the endometrium presenting as paraneoplastic cerebellar degeneration: a case report. Gynecol Oncol. 1999;73:326-330.
Odunsi K, Rutherford TJ, Olive DL, Brown J, Parkash V, Bia F, Zreik TG. Cryomyolosis in the treatment of uterine fibroids: techniques and complications. Surg Technol Int, VIII. 1999;171-174.
Zreik T, Odunsi K, Sarrel P, Olive D. Fatal pulmonary thromboembolism associated with the use of intravenous premarin therapy for menometrorrhagia: a case Report. Fertil Steril. 1999;71:373-375.
Odunsi K., Peck LL, Kohorn EI, Parkash V, Cracchiolo B, Chambers JT, Taylor K. Necrosis of Myometrial Choriocarcinoma with Fulminating Sepsis Complicating Chemotherapy for Trophoblastic Tumor. Gynecol Oncol. 1998;70:100-104.
Odunsi K, Olive D, Rutherford TJ, Zreik TG. Abscess formation in a uterine fibroid treated with cryomyolysis. J Gynecol Tech. 1998;4:115-118.
Odunsi K, Ganesan TS. The roles of the Human Major Histocompatibility Complex and Human Papillomavirus in Cervical Intra-epithelial Neoplasia and Cervical Cancer. Clin Oncol. 1997;9:4-13.
Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS. Susceptibility to Human Papillomavirus associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer. 1996;67:595-602.
Odunsi K, Bullough CHW, Henzel J, Polanska I. Fetal bleeding from vasa praevia: evaluation of existing chemical tests. Int J Gynaecol Obstet. 1996;55:207-212.
Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS. Association between HLA DQB1*03 and cervical intra-epithelial neoplasia. Mol Med. 1995;1:161-171.
Mehal WZ, Lo YMD, Herrington CS, Evans M, Papadopoulos MC, Odunsi K, Ganesan TS, McGee JO'D, Bell JI, Fleming KA. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol. 1994;47:1077-1081.
Okonofua FE, Onwudiegwu U, Odunsi K. Illegal Induced Abortion: A study of 74 new cases in Ile-Ife, Nigeria. Trop Doct. 1992;22:75-78.
Okonofua FE, Odunsi K, Hussain S, O'Brien PMS. Evaluation of the Roll-Over Test as a predictor of gestational hypertension in African Women. Int J Gynecol Obstet.1991;35:37-40.
Okonofua FE, Onwudiegwu U, Odunsi K. Preterm Premature Rupture of Fetal Membranes in a low socio-economic population: Results of conservative management. Int J Gynecol Obstet. 1991;34:35-39.
Okonofua FE, Onwudiegwu U, Odunsi K, Hussain S, O'Brien PMS. Does Standing Up Improve the Predictive Value of the Supine Pressor Test for Gestational Hypertension? Obstet Gynecol. 1990;76:332-335.
Okonofua FE, Ojo OS, Odunsi K, Odesanmi WO. Ectopic Pregnancy Associated with Tubal Schistosomiasis in a Nigerian Woman. Int J Gynecol Obstet. 1990;32:281-284.
Sule-Odu AO, Fakoya TA, Odutayo R, Odunsi K. Advanced Abdominal Pregnancy Complicated by Uterine Prolapse: A case report. Niger Med Pract. 1989;18:49-50.

Publications: Invited and non-peer reviewed

Sabbatini P, Odunsi K. Immunologic approaches to ovarian cancer treatment.. J Clin.Oncol. 2007;25:2884-93.
Singhal P, Tchabo N, Odunsi K. Immunologic markers of cancer progression and prognosis. Exp Opin Med Diagn. 2007;1:439-450.
Odunsi K, Sabbatini P. Harnessing the immune system for ovarian cancer therapy.Amer J Reprod Immunol. 2007;59:62-74.
Odunsi K, Old LJ. Tumor infiltrating lymphocytes: indicators of tumor-related immune responses. Cancer Immun [serial online] 2007; 7:3.
Odunsi K. Cancer Vaccines 2005: Closing remarks. Cancer Immun [serial online] 2006;6 Suppl 1:24.
Villella J, Odunsi K, Lele S. The role of IDO in immune system evasion of malignancy: Another piece to the tolerance puzzle. Cancer Therapy. 2006;4A:427-34. [Epub]
Sharma S, Odunsi K. Targeted therapy for epithelial ovarian cancer. Expert Opin Ther Targets. 2005;9(3):501-13.
Tammela J, Odunsi K. Gene expression and prognostic significance in ovarian cancer.Minerva Ginecol. 2004;56:495-02.
Odunsi K, Lele S, Savalgi R. Vaccine Therapy for Cancer: Fact or Fiction? Surg Technol Int. 2004;13:39-47.
Tammela JE, Lele S, Odunsi K. A human papillomavirus type 16 vaccine (letter). NEJM.2003;348:1402.
Odunsi K. A masterpiece on maternity care in developing countries. Lancet. 2002; 360:1897.
Ghadersohi A, Chitta K, Greco WR, Harvey S, Winston J, Slocum H, Odunsi K, Sood A.Tumor antigens and markers for breast and ovarian cancers. Front Biosci. 2002;7:e48-57.
Pejovic T, Odunsi K. Controversies in ovarian cancer (letter). Am J Obstet Gynecol.2001;184:1310-1311.
Odunsi K, Cooke I, Olive D. Evidence-based medicine: How do we find the evidence? JAm Assoc Gynecol Laparosc. 1998;5:313-318.

Completed Manuscripts

Apetoh L, Smyth MJ, Drake C, Abastado J-P, Blay J-Y, Bonneville M, Butterfield LH, Caignard A , Castelli C, Cavallo F, Celis E, Dhodapkar MV, Gabrilovich DI, Gilboa E, Kalinski P, Kaufman HL, Kiessling R, …, Liblau R, Lugli E, Melero I, … Speiser D, Pardoll DM, Restifo NP, Anderson AC. Consensus nomenclature for CD8+ T cell phenotypes in cancer. Submitted. OncoImmunology
Ajenifuja K, Kolomeyevskaya N, Habib F, Odunsi K, Lele S. Phyllodes Tumor Of Breast Metastasizing T The Vuva Submitted. J Obstet Gyn Research. JOGR-2014-0900
Friel G, Kolomeyevskaya NV, Liu C, Hampras S, Kruszka B, Schmitt K, Canniato R, Lele SB, Odunsi KO, Moysich KB. Aspirin and Acetaminophen use and the risk of cervical cancer. Submitted. Journal of Lower Genital Tract Disease
Szender JB, Frederick PJ, Eng KH, Akers SN, Lele SB, Odunsi K. Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a gynecologic oncology service. Submitted. American Journal of Obstetrics and Oncology.
Khan ANH, Kolomeyevskaya N, Singel KL, Grimm MJ, Moysich K, Daudi S, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH. Targeting Myeloid Cells in the Tumor Microenvironment Enhances Vaccine Efficacy in Epithelial Ovarian Cancer. Submitted. Journal of Immunology
Huang R-Y, Eppolito C, Fadiel A, Wei N-N, Hamza A, Lele S , Shrikant P, Mastuzaki J, Odunsi K. LAG3 and PD1 co-inhibitory molecules directly interact to limit CD8+ T cell signaling.
Tsuji T, Eng K, Gnjatic S, Matsuzaki J, Brightwell R, Miliotto A, Lele S, Emerson R, Desmarais C, Wang J, Liu S, Robins H, Odunsi, K. Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer. Submitted. New England Journal of Medicine
Tumor-associated macrophages: co-conspirators and orchestrators of immune suppression in endometrial adenocarcinoma. Submitted. Gynecologic Oncology
Brightwell RM, Grzankowski K, Kaur J, Poblete S, Miller A, Lele S Sucheston-Campbell L, Moysich K, Odunsi KO. Higher than expected frequencies of non-ovarian cancers within a large Familial Ovarian Cancer Registry. Submitted. Amer J Clinical Exper Obstet Gynec.
Matsuzaki J, Tsuji T, Luescher IF, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses

Books

Okonofua F, Briggs ND, Otubu JA, Odunsi K. Editors. Contemporary Obstetrics and Gynecology for Developing Countries. Women’s Health & Action Research Center, Benin City, Nigeria. 2004.
Odunsi K, Pejovic T. Editors. Gynecological Cancers: A Multidisciplinary Approach to Diagnosis and Management (Current Multidisciplinary Oncology Series). Thomas CR, Series Editor. Demos Medical, New York, NY. 2013.

Book Chapters

Daudi S, Godoy H, Odunsi K. Genomic and Proteomic Biomarkers for Ovarian Cancer Screening, Prognosis and Individualization of Chemotherapy. In: Gynecologic Cancers: A Multidisciplinary Approach to Diagnosis and Management (Current Multidisciplinary Oncology Series).Odunsi K, Pejovic T, Editors, Thomas CR, Series Editor. Demos Medical, New York, NY. 2013; 247-270.
Sabbatini P, Odunsi K, Pfisterer J, Coukos G. Immunotherapy of Gynecologic Malignancies. In: Principles and Practice of Gynecologic Oncology (6th Edition). Barakat RR, Berchuck A, Markman M, Randall ME, editors. Lippencott, Willilams and Wilkins, Philadelphia, PA. 2013; 434-456.
Pejovic T, Anderson M, Odunsi K. Ovarian Cancer. In: Genomic and Personalized Medicine (2nd Edition). Ginsburg GS and Willard HF, editors. Elsevier Inc., Oxford, UK. 2013; 714-721.
Odunsi K, Pejovic T, Anderson M. Molecular Biology of Gynecological Cancers. In: Cancer: Principles and Practice of Oncology (9th Edition). DeVita Jr V, Lawrence T, Rosenberg S, editors. Lippencott Williams & Wilkins, Baltimore, MD. 2011;1302-1310.
van den Broek M, von Boehmer L, Odunsi K, Knuth A. Cancer Immunity and Clinical Oncology. In: Oxford Textbook of Medicine, 5th Edition . Warrell DA, Cox TA, Firth JD, editors. Oxford University Press. USA. 2010; Section 06.04.
Odunsi K. Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology. In: Ernst Schering Foundation Symposium Proceedings 07.4. Kroemer G, Mumberg D, Keun H, Riefke B, Steger-Hartmann T, Peterson K, editors. Springer-Verlag Berlin Heidelberg, New York. 2008; 205-226.
South S, Odunsi K. Preventive strategies and non-invasive treatment options for cervical pre-invasive and invasive disorders. In: Non-invasive management of Gynecologic Disorders. Arici A, Seli E, editors. Informa Healthcare, London, United Kingdom. 2008; 253-269.
Odunsi K, Pejovic T, Anderson M. Molecular Biology of Gynecological Cancers. In: Cancer: Principles and Practice of Oncology (8th Edition). DeVita Jr V, Lawrence T,Rosenberg S, editors. Lippencott Williams & Wilkins, Baltimore, MD. 2008;1487-1496.
Odunsi K, Simpson A, Skipper J, Old L. Cancer vaccines: achievements, challenges and perspectives. In: Cancer in Africa. Ly A and Khayat D, editors. Institut National du Cancer, Cedex, France. 2006; 711-730.
Odunsi K, Odutayo R. Premature rupture of fetal membranes. In: Contemporary Obstetrics and Gynecology for Developing Countries. Okonofua F, Briggs ND, Otubu JA, Odunsi K, editors. Women’s Health & Action Research Center, Benin City, Nigeria. 2004:430-453.
Odunsi K, Gian-Carlo M, Schwartz PES. Radiologic diagnosis of cancer in pregnancy.In: Cancer and Pregnancy. Barnea ER, Jauniaux E, Schwartz PE and Scholfield PE, editors. London: Springer-Verlag. 2001; 81-92.

Kunle Odunsi

Professor

:(716) 845-3497
Fax: (716) 845-7608

DEPARTMENTDivision of Gynecologic Oncology
Roswell Park Cancer Institute
COUNTRY USA